arbor

arbor

59
Reputation
Mid
14 open positions
Last updated Nov 16, 2026
Remote6%
Hybrid0%
On-site94%
Salary shown19%
This month0 new · 0 closed

Principal Research Associate, Protein Engineering

$95k–$110k/year
45
Low

Who we are. Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing mult

Research AssociateLaboratory & Life SciencesLead
See 2 similar>
4 0 0 ~9d ago

Senior Research Associate, In Vivo Pharmacology

20
Lowest

Who we are. Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing mult

Research AssociateLaboratory & Life SciencesSenior
See 2 similar>
4 0 0 ~1mo ago

Senior Research Associate, Histology

20
Lowest

Who we are. Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing mult

Research AssociateLaboratory & Life SciencesSenior
See 2 similar>
5 0 0 ~1mo ago

Scientist/Senior Scientist, Protein Engineering

20
Lowest

Who we are. Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing mult

OtherScientistSenior
See 2 similar>
5 0 0 ~1mo ago

Associate Director, Bioanalytical Sciences & Biomarkers

20
Lowest

Who we are. Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing mult

OtherAssociateExecutive
See 2 similar>
6 0 0 ~1mo ago
arborarbor·(united States)·Remote · Worldwide

Senior Clinical Trial Manager

29
Lowest

Who we are. Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing mult

HealthcareClinical ResearcherSenior
See 2 similar>
5 0 0 ~1mo ago

Senior Scientist, Protein Engineering

19
Lowest

Who we are. Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing mult

OtherScientistSenior
See 2 similar>
6 0 0 ~1mo ago

Director, Analytical Development

20
Lowest

Who we are. Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing mult

OtherDevelopmentExecutive
See 2 similar>
4 0 0 ~1mo ago

Associate Scientist, Protein Engineering

20
Lowest

Who we are. Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing mult

OtherAssociateMid
See 2 similar>
10 0 0 ~1mo ago

Director, Regulatory Affairs

20
Lowest

Who are we? Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing mult

OtherRegulatory AffairsExecutive
See 2 similar>
6 0 0 ~2mo ago

Manager, Regulatory Affairs

20
Lowest

Who are we? Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing mult

OtherRegulatory AffairsMid
See 2 similar>
4 0 0 ~3mo ago

Senior Clinical Trial Manager

20
Lowest

Who are we? Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing mult

HealthcareClinical ResearcherSenior
See 2 similar>
6 0 0 ~3mo ago

Associate Director, Biomarker & Assay Development

20
Lowest

Who are we? Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing mult

OtherDevelopmentExecutive
See 2 similar>
3 0 0 ~4mo ago

Senior Scientist, Pharmacology

20
Lowest

Who Are We? Arbor Biotechnologies™, a next-generation gene editing company based in Cambridge, MA, is advancing a pipeline of novel gene editing therapeutics to address a wide range of genetic conditions – from the ultra-rare to the most common genetic diseases. The company’s unique suite of optimiz

OtherScientistSenior
See 2 similar>
5 0 0 ~4mo ago
arbor Jobs & Careers | 14 Open Positions | Jobera